Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study

Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study

A couple of clinical trials from Harvard researchers have shown that regular consumption of fish or fish oil supplements can reduce the risk of getting heart attacks significantly.

Omega 3 fatty acids contained in fish oils have been known to benefit both people with a healthy heart as well as those with heart disease who are at a greater risk of getting heart attacks or strokes say the researchers.

Sources of omega 3 fatty acids: flaxseeds, avocado, oil capsules and flaxseed oil. Image Credit: Lecic / Shutterstock

Sources of omega 3 fatty acids: flaxseeds, avocado, oil capsules and flaxseed oil. Image Credit: Lecic / Shutterstock

The clinical trial called Vitamin D and Omega-3 Trial (VITAL) showed that people who were taking a fish oil supplement were less likely to get a heart attack especially if they were black or did not take fish regularly. The other trial called Reduction of Cardiovascular Events with Icosapent Ethyl Intervention Trial (REDUCE-IT). Found that taking a purified form of omega-3 fatty acid supplement can reduce the risk of death due to heart disease and heart attacks or stroke. This was especially true for people who had heart risk factors such as atherosclerosis or hardened arteries.

Omega 3 fatty acids are abundantly found in sardines, tuna, salmons and sea fish. They are beneficial for heart health as seen in the studies said Dr. JoAnn Manson, chief of preventive medicine at Brigham and Women’s Hospital in Boston, and lead researcher for the VITAL trial. She said, “We’re not recommending that everyone in the world begin taking fish oil supplements. In terms of the omega 3s, the best thing to do is to try to have more dietary fish… If people aren’t going to eat fish, there really may be some benefits from taking a fish oil supplement. We recommend they discuss that with their health care provider.”

Both of the study results were presented on Saturday at the American Heart Association’s 2018 Scientific Sessions in Chicago and were published in the latest issue of the journal New England Journal of Medicine.

The VITAL Trial

For this trial around 26000 American men and women aged 50 years or older with no history of heart disease were included. They were divided into three groups randomly and asked to take either 1 gram of fish oil or 2,000 International Units of vitamin D or a placebo pill daily. Results showed that those on the fish oil supplements had a 28 percent lowered risk of heart attacks over the five year follow up. Stroke or cancer risk was unaltered with the supplements. The population consuming fewer amounts of dietary fish also had a 19 percent reduction in major heart disease or cardiovascular events and a 40 percent reduction in heart attacks. African American participants were benefited more with the supplements with a 77 percent heart attack risk reduction, write the researchers. Mason explained that heart disease risk was greater among African Americans than for Caucasians and other races. Further vitamin D supplements did not reduce heart disease risk but reduced risk of cancer deaths by 25 percent.

The REDUCE-IT Trial

In this trial pure and stable form of the omega-3 fatty acid known as EPA was tested. A supplement called icosapent ethyl (manufactured and sold as Vascepa by Amarin Corp) is usually prescribed in individuals with raised triglycerides.

For this study the team included over 8000 participants who were already taking statins for cholesterol control. Many of these individuals had already had a heart attack or a stroke in their past. Atherosclerosis or hardened arteries was seen in around 70 percent cases and the other had either diabetes or another heart disease risk factor. They were all given either the supplement or placebo.

Results showed that those patients who were on icosapent ethyl had a 20 percent reduction of the risk of heart related event causing death and a 31 percent reduction in heart attack risk. Stroke risk fell by 28 percent compared to those taking placebo.

Dr. Deepak Bhatt, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital, said in a statement, “The REDUCE-IT trial sets a new standard of care for patients who have elevated triglycerides and are at increased cardiovascular risk despite statin therapy. This may be the biggest development in cardiovascular prevention since statins.”

Mason warned against taking any of the supplements without medical advice.

Tagged with:

About author

Related Articles